The purpose this pragmatic trial to test the effectiveness of an existing, ongoing clinical service, the VA National TeleOncology program (NTO), a multilevel telehealth population health management program. The primary aims are to study the intervention and determine its effectiveness on telehealth engagement, clinical quality, and healthcare cost outcomes across levels of Social Determinants of TeleHealth (SDTH) with the goal of promoting health equity.
Lung Cancer Diagnosis, Colorectal Cancer (Diagnosis), Prostate Cancer Diagnosis, Breast Cancer Diagnosis
The purpose this pragmatic trial to test the effectiveness of an existing, ongoing clinical service, the VA National TeleOncology program (NTO), a multilevel telehealth population health management program. The primary aims are to study the intervention and determine its effectiveness on telehealth engagement, clinical quality, and healthcare cost outcomes across levels of Social Determinants of TeleHealth (SDTH) with the goal of promoting health equity.
Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs
-
VA New York Harbor Healthcare System - Brooklyn, Brooklyn, New York, United States, 11209
VA New York Harbor Healthcare System - St. Albans Community Living Center, Jamaica, New York, United States, 11425
VA New York Harbor Health Care System - Manhattan, New York, New York, United States, 10010
VA New York Harbor Healthcare System - Harlem Community Center, New York, New York, United States, 10027
VA New York Harbor Healthcare System - Staten Island Community Clinic, Staten Island, New York, United States, 10314
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
NYU Langone Health,
Danil Makarov, MD, MHS, PRINCIPAL_INVESTIGATOR, NYU Langone Health
2027-01-01